Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. Case and Commentary Oct 2018 Do Infant Formula Giveaways Undermine or Support Women’s Choices? Stephanie Morain, PhD, MPH and Anne Barnhill, PhD Health care organizations have obligations to support all patients mothering newborns in making informed choices about formula and breast feeding. AMA J Ethics. 2018;20(10):E924-931. doi: 10.1001/amajethics.2018.924. In the Literature Oct 2018 Why Marginalization, Not Vulnerability, Can Best Identify People in Need of Special Medical and Nutrition Care Alexis K. Walker, PhD and Elizabeth L. Fox, PhD Focusing on social processes contributing to marginalization can help clinicians and policy makers mitigate food insecurity risk through improved patient-centered care. AMA J Ethics. 2018;20(10):E941-947. doi: 10.1001/amajethics.2018.941. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
Case and Commentary Oct 2018 Do Infant Formula Giveaways Undermine or Support Women’s Choices? Stephanie Morain, PhD, MPH and Anne Barnhill, PhD Health care organizations have obligations to support all patients mothering newborns in making informed choices about formula and breast feeding. AMA J Ethics. 2018;20(10):E924-931. doi: 10.1001/amajethics.2018.924.
In the Literature Oct 2018 Why Marginalization, Not Vulnerability, Can Best Identify People in Need of Special Medical and Nutrition Care Alexis K. Walker, PhD and Elizabeth L. Fox, PhD Focusing on social processes contributing to marginalization can help clinicians and policy makers mitigate food insecurity risk through improved patient-centered care. AMA J Ethics. 2018;20(10):E941-947. doi: 10.1001/amajethics.2018.941.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.